人工智能在肺癌与间皮瘤中的当前及未来应用
该叙述性综述综合了人工智能在肺癌与间皮瘤管理中的证据,聚焦于病理与放射影像工具。AI在组织学诊断、治疗反应预测、影像检测与量化及生存估计等多学科团队职能中展现潜力,尤其在间皮瘤分割与肺癌筛查路径支持方面有优势。未来研究应注重透明可解释的输出。
要点
- 病理图像训练的神经网络可用于组织学分类、预后、反应预测与生存分析。
- 放射学AI工具支持肺结节检测,为肺癌筛查与紧急转诊提供关键路径支持。
- 肿瘤分割AI在间皮瘤中优势突出,因肿瘤大小与形态复杂使人工评估困难。
核心结论
- AI在基于病理和放射影像的重复或耗时任务中可为多学科团队带来显著潜在获益。
- 有效利用该技术对肺癌筛查及高效提供日益复杂的诊断与预测功能至关重要。
- 未来AI研究应涉及透明可解释的输出,以辅助解释AI支持决策的依据。
研究设计与样本
- 本文为叙述性综述(state-of-the-art narrative review),综合该主题证据,重点聚焦输入常规病理和放射影像图像的工具。
主要发现
- 病理图像训练的神经网络在组织学分类、预后、反应预测和生存方面有实用价值。
- 自监督模型可生成对导致不良结局的生物学特征的新见解。
- 放射学应用包括肺结节工具,为即将开展的肺癌筛查和紧急转诊提供关键路径支持。
- 肿瘤分割AI在间皮瘤中优势明显,因肿瘤大小和形态复杂性使人工评估反应和体积分期困难。
- AI对放射基因组学至关重要,可有效整合分子与放射组学特征以发现无创分子亚型标志物并增强分层。
临床怎么用
- AI工具可辅助多学科团队完成基于病理和放射影像的重复或耗时任务,提升效率。
- 肺结节AI工具可支持肺癌筛查路径和紧急转诊流程。
- 间皮瘤中可借助肿瘤分割AI辅助反应评估和体积分期。
- 放射基因组学AI有助于发现无创分子亚型标志物并改善分层。
局限性
- 实施障碍包括获取高质量训练数据以及合适的监管和技术基础设施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Considerable challenges exist in managing lung cancer and mesothelioma, including diagnostic complexity, treatment stratification, early detection and imaging quantification. Variable incidence in mesothelioma also makes equitable provision of high-quality care difficult. In this context, artificial intelligence (AI) offers a range of assistive/automated functions that can potentially enhance clinical decision-making, while reducing inequality and pathway delay. AIMS: In this state-of-the-art narrative review, we synthesise evidence on this topic, focusing particularly on tools that ingest routine pathology and radiology images. We summarise the strengths and weaknesses of AI applied to common multidisciplinary team (MDT) functions, including histological diagnosis, therapeutic response prediction, radiological detection and quantification, and survival estimation. We also review emerging methods capable of generating novel biological insights and current barriers to implementation, including access to high-quality training data and suitable regulatory and technical infrastructure. NARRATIVE: Neural networks trained on pathology images have proven utility in histological classification, prognostication, response prediction and survival. Self-supervised models can also generate new insights into biological features responsible for adverse outcomes. Radiology applications include lung nodule tools, which offer critical pathway support for imminent lung cancer screening and urgent referrals. Tumour segmentation AI offers particular advantages in mesothelioma, where response assessment and volumetric staging are difficult using human readers due to tumour size and morphological complexity. AI is also critical for radiogenomics, permitting effective integration of molecular and radiomic features for discovery of non-invasive markers for molecular subtyping and enhanced stratification. CONCLUSIONS: AI solutions offer considerable potential benefits across the MDT, particularly in repetitive or time-consuming tasks based on pathology and radiology images. Effective leveraging of this technology is critical for lung cancer screening and efficient delivery of increasingly complex diagnostic and predictive MDT functions. Future AI research should involve transparent and interpretable outputs that assist in explaining the basis of AI-supported decision making.
引用
- Roche JJ, Seyedshahi F, Rakovic K, et al. Current and future applications of artificial intelligence in lung cancer and mesothelioma. Thorax. 2025. PMID: 40541405. doi:10.1136/thorax-2024-222054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。